Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxis (original) (raw)

Targeted Routine Antenatal Anti-D Prophylaxis in the Prevention of RhD Immunisation - Outcome of a New Antenatal Screening and Prevention Program

Agneta Wikman

PLoS ONE, 2013

View PDFchevron_right

Anti-D Prophylaxis Reviewed in the Erea of Foetal RHD Genotyping

Jean-marc Minon

Journal of Blood Disorders & Transfusion, 2015

View PDFchevron_right

Noninvasive fetal RHD genotyping to guide targeted anti‐D prophylaxis–an external quality assessment workshop

Carlos Cotorruelo

Vox Sanguinis, 2019

View PDFchevron_right

The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible

Werner Stein

…, 2008

View PDFchevron_right

Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping

Barbora Dybvik

Fetal Diagnosis and Therapy

View PDFchevron_right

Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies

Agneta Wikman

Acta Obstetricia et Gynecologica Scandinavica, 2013

View PDFchevron_right

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis

Joke Koelewijn

BJOG: An International Journal of Obstetrics & Gynaecology, 2009

View PDFchevron_right

Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma

Primož Rožman

Transfusion Medicine and Hemotherapy, 2013

View PDFchevron_right

Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation

Hazel Squires

Health technology assessment (Winchester, England), 2009

View PDFchevron_right

A new fetal RHD genotyping test: Costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales

Ala Szczepura

BMC Pregnancy and Childbirth, 2011

View PDFchevron_right

Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium

Christiane Gérard

Transfusion, 2007

View PDFchevron_right

A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant

Catherine Beverley

BJOG: An International Journal of Obstetrics & Gynaecology, 2004

View PDFchevron_right

Noninvasive Antenatal Diagnosis of Fetal RhD Status

D. Plaseska

Journal of Advances in Medicine and Medical Research

View PDFchevron_right

Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark

Rudi Steffensen

Prenatal Diagnosis, 2014

View PDFchevron_right

High-throughput, non-invasive prenatal testing for fetal rhesus D status in RhD-negative women: a systematic review and meta-analysis

Pedro Saramago

BMC Medicine

View PDFchevron_right

Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study

Geoff Poole

BMJ, 2008

View PDFchevron_right

Diagnostic performance of the noninvasive prenatal FetoGnost RhD assay for the prediction of the fetal RhD blood group status

Irina Korschineck

Archives of Gynecology and Obstetrics

View PDFchevron_right

Rh isoimmunization in Sub-Saharan Africa indicates need for universal access to anti-RhD immunoglobulin and effective management of D-negative pregnancies

PROFESSOR OSARO ERHABOR

International Journal of Women's Health, 2010

View PDFchevron_right

One single dose of 200 μg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

Joke Koelewijn

Transfusion, 2008

View PDFchevron_right

The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative

Myfanwy Jones

BJOG: An International Journal of Obstetrics & Gynaecology, 2004

View PDFchevron_right

Routine Administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice

julie kent

View PDFchevron_right

Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation‐wide population study prior to routine antenatal anti‐D prophylaxis

Hulda Hjartardottir

Transfusion, 2019

View PDFchevron_right

The Determination of Fetal RhD Status from Maternal Blood in Serbia

Prof.dr Snezana D Plesinac

Indian Journal of Hematology and Blood Transfusion, 2018

View PDFchevron_right

Detection of fetal messenger ribonucleic acid in maternal blood to determine fetal RhD status as a strategy for noninvasive prenatal diagnosis

Nicholas Fisk

American Journal of Obstetrics and Gynecology, 1998

View PDFchevron_right

Non-invasive prenatal diagnosis and determination of fetal Rh status

Sinuhe Hahn

Seminars in Fetal and Neonatal Medicine, 2008

View PDFchevron_right

RhD immunisation in pregnancy

Hans Erik Heier

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016

View PDFchevron_right

Non-invasive antenatal RHD typing

Joke Koelewijn

Transfusion Clinique et Biologique, 2006

View PDFchevron_right

J Kent, AM Farrell and P Soothill, ‘Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice’, (2014) BMC Pregnancy and Childbirth 14: 87.

Anne-Maree Farrell

View PDFchevron_right

Detection of fetal RhD gene from maternal blood

Tuba Gunel, Hayri Ermiş

Journal of the Turkish German Gynecological Association, 2010

View PDFchevron_right

RH D Foeto-Maternal Alloimmunization Prophylaxis with Anti-D Immunoglobulins Reviewed in the Era of Foetalrhdgenotyping

Christiane Gerard

Acta Clinica Belgica, 2009

View PDFchevron_right

Fetal RHD genotyping by analysis of maternal plasma in a mixed population

Dulcinéia Albuquerque

Journal of Clinical Laboratory Analysis, 2011

View PDFchevron_right

Clinical application of midtrimester non-invasive fetal RHD genotyping and identification of RHD variants in a mixed-ethnic population

Antoni Borrell

Prenatal Diagnosis, 2013

View PDFchevron_right

The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation

Angelo Dalessandro

2010

View PDFchevron_right

Evaluation of non-invasive prenatal RHD genotyping of the fetus

gardener gardener

2010

View PDFchevron_right